Direct to phase II sbir concept award for novel iontophoretic drug delivery device for local and effective treatment of oral cancer
Active Definitive Contract Awarded Last action
- Contract number
- 75N91025C00024
- Awardee
-
Continuity Biosciences, LLC UEI KTR8EE8DBFX5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,995,581
Award facts
- Contract value 100% obligated
- $2,995,581.00 Current and potential, with all options
- Completion date 56% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 16 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Cary, NC 27513, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,995,581 |
About this award
The National Cancer Institute awarded a $2,995,581 definitive contract to Continuity Biosciences, LLC on September 5, 2025, under a total small business set-aside, for a Direct to Phase II SBIR concept award addressing a novel iontophoretic drug delivery device for local and effective treatment of oral cancer.
Place of performance is Cary, NC. The ultimate completion date is September 4, 2027. The contract carries firm fixed price terms.
In fiscal 2025, the prime self-performed the contract with 0.1 FTEs and invoiced $300 thousand in government-paid labor, with no subcontractor engagement reported.
Quick answers
Who was awarded contract 75N91025C00024?
75N91025C00024 was awarded to Continuity Biosciences, LLC by National Cancer Institute (National Institutes of Health) on September 5, 2025.
How much is contract 75N91025C00024 worth?
The government has obligated $2,995,581 on 75N91025C00024.
Was contract 75N91025C00024 competed?
The extent of competition for 75N91025C00024 was full and open competition after exclusion of sources. The government received 16 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award